Lone Star Funds Announces Sale of Japanese Rental Property Portfolio Tokyo β
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Real Estate Fund VI, L.P. has successfully completed the sale of Tokyo β (“Tokyo Beta”), one of the largest rental property assets in Tokyo.
Tokyo Beta was formed by Lone Star following the successful purchase of over one thousand non-performing loans in Japan between early 2020 and late 2022. Following its acquisition, Lone Star restructured the management of nearly 1,200 shared houses from a total of more than 200 different individual property managers, to streamline operations on a single coordinated platform of affordable rental units designed for and utilized by young professionals and students.
Today, total rentable rooms in the rebranded Tokyo Beta portfolio exceeds 16,000, comprising one of the largest rental property assets in Tokyo. New services introduced recently include a smartphone rental app, simplified check-in and check-out, energy saving utilities and fixtures, and commuter friendly electric scooters, all to further appeal to a new generation of young renters in the region.
“Today’s announcement is the culmination of several years of work to successfully restructure and revitalize this portfolio, making it one of the most attractive rental communities in Tokyo,” said Jérôme Foulon, Global Head of Commercial Real Estate for Lone Star.
“This portfolio highlights Lone Star’s willingness and ability to develop strong and promising businesses serving not only our investors but also Japanese consumers with improved products and services,” added Mitsuo Matsunaga, head of Lone Star in Japan.
Lone Star’s investment platform in Japan has been actively investing in the country for over 28 years. Over that period, Lone Star has committed $9.6 billion in equity capital to assets in the region across nearly 90 investments, making it one of the most active investors in the region.
About Lone Star
Lone Star is a leading private equity firm advising funds that invest globally in corporate equity, credit, real estate and other financial assets. Since the establishment of its first fund in 1995, Lone Star has organized 25 private equity funds with aggregate capital commitments totaling approximately $95 billion. The firm organizes its funds in three series: the Opportunity Fund series; the Commercial Real Estate Fund series; and the U.S. Residential Mortgage Fund series. Lone Star invests on behalf of its limited partners, which include institutional investors such as pension funds and sovereign wealth funds, as well as foundations and endowments that support medical research, higher education, and other philanthropic causes. For more information regarding Lone Star Funds, go to www.lonestarfunds.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250401414123/en/
Contacts
mediarelations@lonestarfunds.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FlexTrade First Provider to Offer Goldman Sachs Order Status Updates via API3.4.2025 13:02:00 EEST | Press release
FlexTrade Systems (@FlexTrade), a global leader in multi-asset execution and order management systems, has today announced that Goldman Sachs' real-time Order Status Updates (OSUs) for algorithmic orders can be streamed directly into FlexTrade’s OEMS Order Blotter via a new proprietary API – fundamentally changing how Goldman Sachs delivers data to buy-side clients. The announcement is part of Goldman Sachs’ new suite of real-time alerting and data analytics offering, GS Alerts, which is aimed at providing clients with seamless access to metrics from within their EMS/OMS blotter. The new OSUs package offers metrics for orders in developed and emerging markets in EMEA equities, including expected residuals, estimated quantity reserved for the close, and the average participation rate of the order. Using a new API to deliver OSU data, rather than FIX, opens new possibilities regarding the frequency and type of data being delivered to FlexTrade clients, eliminating unnecessary overheads c
Articy Software launches articy:draft X on Mac OS – A New Era for Narrative Design3.4.2025 13:00:00 EEST | Press release
No longer a Windows-exclusive tool, articy:draft X , the leading narrative design software, is now officially available on Mac OS. This highly anticipated release marks a significant milestone in Articy's journey, opening doors for a new wave of creators and storytellers who have been eager to harness its powerful features on their preferred platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250403045197/en/ articy:draft X has become a cornerstone for narrative designers, game developers, and storytellers worldwide, providing a robust set of tools for interactive story creation, complex dialogue structuring, scripting, and seamless world-building complete with localization, voice over and dedicated engine exports. With its launch on Mac OS, the software is now accessible to an even broader community, empowering creators to design captivating stories and intricate game worlds, regardless of the operating system. Bringin
BeiGene Provides Update on the Ociperlimab (BGB-A1217) Clinical Development Program3.4.2025 13:00:00 EEST | Press release
BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the discontinuation of its clinical development program for ociperlimab (BGB-A1217), an anti-TIGIT antibody, as a potential treatment for lung cancer. The Independent Data Monitoring Committee recommended terminating the ongoing Phase 3 AdvanTIG-302 trial (NCT04746924) based on its findings as part of a pre-planned futility analysis. The overall efficacy and safety data assessment suggested that the study was unlikely to meet the primary endpoint of overall survival. No new safety signals were observed. After thorough deliberation, the Company has made the decision to terminate the trial. “We evaluate our clinical programs to focus our resources on the most promising clinically differentiated candidates while thoughtfully de-prioritizing others. Our commitment remains steadfast: to discover and develop innovative treatments that are m
BearingPoint client success story: Driving digital continuity in product development through a data management hub3.4.2025 12:08:00 EEST | Press release
As vehicle development becomes increasingly complex with the transition to electromobility and the integration of software across almost all components, seamless coordination among specialized departments involved is more critical than ever. At the same time, competitive pressures demand shorter development cycles, making traditional methods of data exchange, such as point-to-point interfaces or manual processes, less efficient and prone to inconsistencies. However, a high level of data consistency is essential to ensure smooth development, integration, and validation, particularly in the development of electric control units and onboard communication systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250403719346/en/ BearingPoint is supporting BMW Group in establishing a central data hub to create a high-quality data foundation for the electrical/electronics (E/E) development process to enable cross-departmental digita
Philip Morris International Releases Integrated Report Detailing Progress Towards Its Smoke-Free Vision3.4.2025 11:30:00 EEST | Press release
Philip Morris International Inc. (NYSE: PM) today published its sixth annual Integrated Report, marking the company’s 10th year of business transformation and sustainability disclosures. The document details PMI’s continued progress in delivering long-term value to shareholders and other stakeholders while advancing its purpose of having its smoke-free alternatives make cigarettes obsolete as soon as possible. “Our 2024 Integrated Report celebrates a milestone year that marked the 10thanniversary of the commercialization of IQOS, VEEV and ZYN and our journey toward achieving one of the most ambitious business transformations in modern history,” said Jacek Olczak, Chief Executive Officer of PMI. “By the end of 2024,our efforts to expand access to smoke-free products allowed us to reach an estimated 38.6 million adult users, with the products available in 95 markets, demonstrating our deep commitment to sustainability and business transformation. These achievements fill me with profound
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom